Home › Forums › Main Forum › Media & News › Indian generics expected to get the green light
- This topic has 4 replies, 5 voices, and was last updated 9 years ago by honker.
-
AuthorPosts
-
30 November 2015 at 5:29 am #4850
NEW DELHI: In a move that comes as a huge relief to patients of chronic Hepatitis C, the apex committee of the Central Drugs Standard Control Organisation (CDSCO) has granted a waiver of local trials for crucial new direct-acting antiviral drugs treating the disease.
The waiver for sofosbuvir and ledipasvir co-formulation and for daclatasvir is expected to bring the generic version of these drugs, which cost a fraction of the branded versions, into the Indian market within weeks. Some patients facing a threat to life currently import these drugs at a huge cost.
According to the World Health Organisation, about 12 million people are infected with Hepatitis C in India. India is now one of the few countries where generics are available for interferon-free treatment. Pegylated interferon is an old, expensive, injectable chemotherapy drug with serious side effects used to treat Hep C in combination with sofosbuvir and ribavirin.
YMMV
30 November 2015 at 8:43 am #4859But next door in Pakistan there is interference from interferon…
“in the process of preparing guidelines at the national level but since they still have over 0.3million vials of interferon, they have decided to wait until the stock ends.”
30 November 2015 at 11:22 am #4870Joy wrote:But next door in Pakistan there is interference from interferon…
“in the process of preparing guidelines at the national level but since they still have over 0.3million vials of interferon, they have decided to wait until the stock ends.”
Getting rid of the “Rat Poison” first.
Two time relapser.
SVR 4 achieved 12/16 at last
SVR 12 achieved 22/02/2017 The Bastard has been defeatedGT 3 – about 28 yrs with HCV
30 November 2015 at 1:25 pm #4882Sounds like NHS England, although hopefully now, this will become less and less.
GT1a Dec14 F2/8.7 VL 900000-2.5M
Jan16 Hepcivir-L MonkMed/Redemption
Baseline: VL 913575 Alt 76 Platelets low
Wk2 VL1157 Alt 23
DET Wk 8 VL 32 Alt19 ‘In the slow lane’
June16 Fibro 5.7 F0/1 LIF 1.5
Wk 11 VL<12 Alt 13 Det/Unq
Extending tx 12 wks Mylan Sofo/Dac MonkMed
Wk 14 VL <12 Det/Unq
Wk 16 VL UNDETECTED
Wk 22 + 4 Wks Sunprevir FixHepC
Wk 24 UNDETECTED Alt 13
Wk 12 post tx SVR12 Wk 26 SVR24
Thank-you Tim, Dr Debasis @ MonkMed & Dr Freeman @ Fix HepC9 December 2015 at 4:55 pm #5698We have a very similar Hep C profile. It is encouraging to know of your success. All the best to you.
Diagnosed in 2000, Genotype 1(b), no previous treatment,
Viral Load 90,700, ALT 86, AST 56 (as of Novemeber 15, 2015)
Fibroscan F0
Starting Redemption Sof/Led on February 2, 2016
Thanks to Greg Jeffries, Monkmed , FixHepC and Dr. FreemanFeb. 29
Week 5 of tx
ALT 23
UndetectedMay 26
4 EOT
ALT 25
AST 28Didn’t test for viral load. Will test is July at 12 weeks EOT
August 1
Liver enzymes in normal range
HCV UNDETECTED -
AuthorPosts
- You must be logged in to reply to this topic.